Artiva Biotherapeutics (ARTV) Assets Average (2024 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Assets Average for 2 consecutive years, with $139.9 million as the latest value for Q4 2025.
- For Q4 2025, Assets Average fell 35.7% year-over-year to $139.9 million; the TTM value through Dec 2025 reached $139.9 million, down 35.7%, while the annual FY2025 figure was $170.3 million, 8.21% up from the prior year.
- Assets Average hit $139.9 million in Q4 2025 for Artiva Biotherapeutics, down from $159.1 million in the prior quarter.
- Across five years, Assets Average topped out at $217.6 million in Q4 2024 and bottomed at $139.9 million in Q4 2025.